Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP219514.RA_Dd2ftwB0jOjfNczQDCmvttki2tByRwvzfYeeDyI_hA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP219514.RA_Dd2ftwB0jOjfNczQDCmvttki2tByRwvzfYeeDyI_hA130_assertion type Assertion NP219514.RA_Dd2ftwB0jOjfNczQDCmvttki2tByRwvzfYeeDyI_hA130_head.
- NP219514.RA_Dd2ftwB0jOjfNczQDCmvttki2tByRwvzfYeeDyI_hA130_assertion wasGeneratedBy ECO_0000203 NP219514.RA_Dd2ftwB0jOjfNczQDCmvttki2tByRwvzfYeeDyI_hA130_provenance.
- NP219514.RA_Dd2ftwB0jOjfNczQDCmvttki2tByRwvzfYeeDyI_hA130_assertion wasDerivedFrom befree-20150227 NP219514.RA_Dd2ftwB0jOjfNczQDCmvttki2tByRwvzfYeeDyI_hA130_provenance.
- NP219514.RA_Dd2ftwB0jOjfNczQDCmvttki2tByRwvzfYeeDyI_hA130_assertion SIO_000772 16916543 NP219514.RA_Dd2ftwB0jOjfNczQDCmvttki2tByRwvzfYeeDyI_hA130_provenance.
- NP219514.RA_Dd2ftwB0jOjfNczQDCmvttki2tByRwvzfYeeDyI_hA130_assertion evidence source_evidence_literature NP219514.RA_Dd2ftwB0jOjfNczQDCmvttki2tByRwvzfYeeDyI_hA130_provenance.
- NP219514.RA_Dd2ftwB0jOjfNczQDCmvttki2tByRwvzfYeeDyI_hA130_assertion description "[BCR/ABL-positive acute myeloid leukemia (AML) is a rare disease, characterized by a poor prognosis, with resistance to induction chemotherapy and frequent relapses in responsive patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219514.RA_Dd2ftwB0jOjfNczQDCmvttki2tByRwvzfYeeDyI_hA130_provenance.